C

비피도

238200KOSDAQ기타 식품 제조업

45.1 / 100

Reference Date: 2026-06-10

Financial Score20.0 / 40
News Sentiment13.1 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 20.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Bifido is a company that produces probiotic raw materials and finished products based on physiologically active bifidobacteria strains discovered by Professor Ji Geun-eok in 1994. It holds FDA NDI and GRAS certifications and utilizes the MAP platform technology to develop functional probiotics and microbiome-based therapeutics. The company is also expanding into B2C markets through the development of individually recognized probiotic raw materials.

Number of Employees

102people

Average Salary

42.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 13.214.0Point
PBR
0.39Industry Average 0.565.5Point

Lower than industry avg (good)

ROE
-0.42Industry Average 2.720.0Point

Well below industry avg

Debt Ratio
1.00Industry Average 11.918.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲12.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼537.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -3.1% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 2Negative 0Average Sentiment Score 52.5

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 2,215Won52-week high 4,33552-week low 2,215
1-month return0.0Point

1m -20.89% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral[기재정정]주요사항보고서(유형자산양도결정)2026-05-19
  • Neutral분기보고서 (2026.03)2026-05-15